Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
ST. LOUIS–(BUSINESS WIRE)–Particle Dynamics, a leader in oral solid dosage (OSD) technologies for the pharmaceutical sector, has announced the appointment of industry veteran Mike Kanan as its new Chief Financial Officer. Mike’s appointment marks a significant milestone for Particle Dynamics, … Learn more